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Abstract
Background: Canine leishmaniasis caused by Leishmania infantum is a parasitic disease of great veterinary significance.
Some dogs infected by L. infantum may mount a strong cellular immune response and clear the infection, while others
may respond with exaggerated antibody production against the parasite and develop an overt disease, which may be
fatal, if left untreated. The initial factors triggering the polarization of the immune response towards a predominantly
T-helper 1 or T-helper 2 cytokines, as well as the markers of resistance and susceptibility to L. infantum infection and
disease development in dogs, are not fully understood. Herein, we assessed the association between single nucleotide
polymorphisms (SNPs) in the canine β-defensin-1 (CBD1) gene and the infection by L. infantum in two dog populations
from Brazil (Sobral in Ceará State and São Raimundo Nonato in Piauí State) and one dog population from Italy.
Results: A total of 387 dogs were assessed for L. infantum by real time PCR and 34.6% of them were positive. In CBD1
gene sequences from these positive dogs, nine polymorphic sites were detected, but only SNPs 3, 4, 7 and 8 were
associated with L. infantum, in dogs from southern Italy. No association was found with dogs from Brazil.
Conclusion: This study sets the basis for further studies on the usefulness of CBD1 as a marker of L. infantum infection
susceptibility in dogs.
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Background
Canine leishmaniasis (CanL) is a disease caused by sand
fly-transmitted protozoa of the genus Leishmania, which
affects dogs in all continents, except Oceania [1]. From a
global perspective, the most common causative agent of
the disease is Leishmania infantum, the agent of zoonotic
visceral leishmaniasis in humans. CanL caused by L. infan-
tum is a widespread, life-threatening disease characterized
by several, usually non-specific, clinical signs, such as
weight loss, enlargement of lymph nodes, spleen and liver,
lethargy, cutaneous and ocular lesions [2]. However, most
of the L. infantum-infected dogs present neither evident
clinical signs nor clinico-pathological abnormalities, being
generally resistant to the infection [1, 2].
The variable clinical presentation of CanL depends on
several predisposing factors, including breed, age and
genetic background [2]. The development of overt dis-
ease is also dependent on the predominant type of im-
mune response mounted by the dog against the
parasites. It is known that a dominant T-helper 1 (Th1)
cell-mediated immune response may lead to the reso-
lution of infection, whereas an exaggerated T-helper 2
(Th2) cell proliferation can lead to a high antibody pro-
duction, with the formation of immune complexes,
which lead to clinical signs such as vasculitis, arthritis,
uveitis, and glomerulonephritis [2, 3]. Undoubtedly, still
many gaps remain about the initial factors triggering the
polarization of the immune response as well as regarding
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the susceptibility and resistance markers for L. infantum
infection in dogs.
Several studies have assessed the usefulness of im-
munological markers of susceptibility and resistance to
L. infantum infection in dogs. For example, interleukin
10 (IL-10), tumour growth factor beta (TGF-β) and
interleukin 4 (IL-4) are associated with increased B-cell
and plasma-cell activity and hyperglobulinemia, and with
disease susceptibility in dogs [3]. On the other hand, in-
creased levels of interferon gamma (IFN-γ), interleukin 2
(IL-2) and tumour necrosis factor alpha (TNF-α) induce
macrophage activation and nitric oxide intracellular kill-
ing of parasites, which is associated to resistance in nat-
urally infected dogs [3–6]. Thus, the profile of the host
immune response has been used as a marker of suscepti-
bility or resistance to L. infantum infection in dogs.
It has been suggested that host genetics play a role in
the susceptibility to CanL. For instance, the solute carrier
family 11 member 1 gene (SLC11A1), formerly named
resistance-associated macrophage protein 1 (NRAMP1)
gene, and certain alleles of the major histocompatibility
complex II (MHC II) genes have been associated with sus-
ceptibility to CanL [7, 8]. In a recent study, ~170,000 sin-
gle nucleotide polymorphisms (SNPs) were genotyped in
dogs and associations between L. infantum infection and
polymorphisms were found in several genes (e.g. Il7R, Lifr,
C6, C7 and Csf1r genes), within a locus involved in lesion
development in murine Leishmania major infection [9].
The association between SNPs and L. infantum in-
fection or disease development in dogs is not so clear,
since leishmaniasis is a complex disease whose pro-
gression is associated with multiple gene loci [10].
SNP analysis of innate immunity genes, such as those
coding for antimicrobial peptides (AMPs), could pro-
vide interesting insights into the relationship between
host’s genetics and L. infantum infection in dogs.
Herein, we used molecular tools to determine the in-
fection by L. infantum in dogs, living in three areas
where CanL is endemic, and investigated the possible
relationship between polymorphisms in the canine β-
defensin-1 (CBD1) gene and positivity to L. infantum,
as previous studies have demonstrated the association
of polymorphisms in this gene and diseases in dogs
[11, 12].
Methods
Dog populations and samples
A total of 387 mongrel dogs were included in this study,
of which 95 from São Raimundo Nonato (09°00'54"S, 42°
41'56"W), Piauí State, and 190 from Sobral (3°41'15"S,
40°21'5"W), Ceará State, north-eastern Brazil. Addition-
ally, 102 dogs from Putignano (40°51'N, 17°7'E), Apulia
region in southern Italy, were also included. Samples
from Brazil were primarily collected for this study. The
samples from Italy came from a previous study [13]. The
selected populations live in known endemic areas of
CanL. Venous blood samples (5 ml) from all dogs were
collected in tubes containing anticoagulant and stored at
4 °C until DNA extraction.
Molecular procedures
DNA extraction
DNA extraction from whole blood samples was per-
formed using the salting-out method [14], for the
Brazilian samples, and a commercial kit (MagAttract
DNA Blood kit, Qiagen, Valencia, California, USA),
for the Italian samples. Each extracted DNA sample
was quantified by NanoDropTM 2000 (Thermo Scien-
tific, Wilmington, Delaware, USA) to determine its
concentration and purity.
Leishmania DNA detection
For L. infantum detection, the primers LEISH-1 (5'-AAC
TTT TCT GGT CCT CCG GGT AG-3'), LEISH-2 (5'-
ACC CCC AGT TTC CCG CC-3') and the TaqMan®
probe FAM-5'-AAA AAT GGG TGC AGA AAT-3'-non-
fluorescent quencher-MGB were used as described else-
where [13, 15]. These primers target the conserved region
of L. infantum of the kinetoplast DNA minicircles con-
served region and amplify a fragment of 120 bp [16]. Para-
site load was estimated using a standard DNA curve
ranging from 1 ng to 0.1 fg of L. infantum (MHOM/BR/
76/M4192) genomic DNA, as described elsewhere [15].
The standard curve and a negative control (no template
DNA) were included in each PCR run, which were per-
formed on an QuantStudio® 5 Real-Time PCR system (Ap-
plied Biosystems, Foster City, California, USA), in a final
volume of 15 μl, containing 2 μl of DNA, 2.5 μl of
nuclease-free water, 1.35 μl of each primer at 900 nM,
0.3 μl of TaqMan® probe at 200 nM and 7.5 μl of TaqMan®
Fast Advanced Master Mix (Applied Biosystems, Foster
City, California, USA). The cycling conditions were as fol-
lows: initial denaturation at 95 °C for 20 s, 40 cycles at
95 °C for 1 s and 60 °C for 20 s [15].
Data analysis was performed using QuantStudio®
Design and Analysis Software v1.3.1 (Applied Biosys-
tems, Foster City, California, USA). PCR-positive dogs
were defined as cases and PCR-negative dogs as con-
trols. The parasite load was categorized as described
elsewhere [15], considering the estimated number of
parasites per ml of blood as follows: low (0–10 para-
sites), medium (11–100 parasites), high (101–1000
parasites) or very high (>1000 parasites).
CBD1 gene and SNP analysis
Primers for CBD1 (DEFEX1FW 5’-ATC CCT GCC CTA
TAA ATA CCG-3’ and DEFEX1RW 5'-CCA AAC ACA
GTC AGG GAT G-3') were designed using the
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Primer3Plus software [17], using Canis lupus famil-
iaris genomic sequences deposited in the GenBank
(NC_006598 for the DEFB1 gene). The primers were
designed to amplify the region between the promoter
and intron 1 of the CBD1 gene with an expected
amplicon size of 582 bp. The OligoAnalyzer software
(http://www.idtdna.com/analyzer/applications/oligoanalyzer)
was used to verify the quality of the selected primers based
on the observation of the following criteria: melting
temperature definition, primer dimer and hairpins forma-
tion. PCR standardization was performed in a final volume
of 25 μl containing: 1.5 μl of each primer at a concentration
of 10 pmol/μl; 7.5 μl of nuclease-free water, 12.5 μl of
GoTaq Master Mix (Promega, Madison, Wisconsin, EUA)
and 2 μl of DNA. The amplification profile was defined
according to the melting temperature of the primer. A
gradient was performed to find the perfect annealing
temperature and the number of cycles was defined by the
size of the fragment specific to the primer.
The amplification conditions for the CBD1 gene were
as follows: initial denaturation at 94 °C for 5 min, 35 cy-
cles of (94 °C/30 s, 55 °C/30 s and 72 °C/30 s), and final
extension at 72 °C for 10 min. The amplified products
were analysed in 0.5% agarose gels, containing 1% of
ethidium bromide and visualized with an ultraviolet
transilluminator. All products were sequenced using
same primers and the BigDye® Terminator v3.1 cycle se-
quencing kit (Applied Biosystems, Foster City, California,
USA), in a Genetic Analyzer 3500 (Applied Biosystems,
Foster City, California, USA).
Consensus sequences were generated based on the
Phred 40 values using the Staden package [18] and
Table 1 Association between genetic polymorphisms in β-defensin-1 and with Leishmania infantum in dogs from Sobral, Brazil
SNP Variation ID Positiona Alleles HWE Possible
genotype
Total
frequency
(n = 190)
Frequency
in cases
(n = 70)
Frequency
in controls
(n = 120)
Odds ratio
(95% CI)
Logistic
regression
(P-value)
SNP1 rs852527703 58881447 C/T 0.14 T/T 0.23 0.19 0.25 0.51 (0.22–1.15) 0.17
C/T 0.44 0.40 0.47 0.59 (0.30–1.15)
C/C 0.33 0.41 0.28 1.00
SNP2 rs852380685 58881356 C/T 0.14 T/T 0.23 0.19 0.25 0.51 (0.22–1.15) 0.17
C/T 0.44 0.40 0.47 0.59 (0.30–1.15)
C/C 0.33 0.41 0.28 1.00
SNP3 rs850814192 58881297 A/G 0.59 G/G 0.51 0.49 0.52 1.00 0.73
A/G 0.42 0.43 0.42 1.11 (0.60–2.06)
A/A 0.07 0.09 0.06 1.59 (0.49–5.10)
SNP4 rs852670798 58881294 A/C 0.77 C/C 0.30 0.31 0.29 1.00 0.87
A/C 0.51 0.49 0.52 0.86 (0.44–1.69)
A/A 0.19 0.20 0.18 1.01 (0.43–2.38)
SNP5 rs852439766 58881277 C/T 0.082 T/T 0.25 0.26 0.25 1.00 0.89
C/T 0.56 0.54 0.57 0.92 (0.45–1.86)
C/C 0.18 0.20 0.18 1.11 (0.45–2.72)
SNP6 rs850643698 58881159 A/G 0.77 G/G 0.19 0.20 0.18 1.01 (0.43–2.38) 0.87
A/G 0.51 0.49 0.52 0.86 (0.44–1.69)
A/A 0.30 0.31 0.29 1.00
SNP7 rs853079810 58881122 A/G 0.19 G/G 0.25 0.26 0.25 1.00 0.91
A/G 0.55 0.53 0.56 0.92 (0.45–1.87)
A/A 0.20 0.21 0.19 1.09 (0.45–2.61)
SNP8 rs851268228 58881093 C/T 1 T/T 0.08 0.10 0.07 1.57 (0.53–4.71) 0.72
C/T 0.41 0.40 0.41 1.03 (0.55–1.92)
C/C 0.52 0.50 0.52 1.00
SNP9 rs850702571 58881081 A/G 0.24 G/G 0.48 0.50 0.48 1.00 0.88
A/G 0.39 0.37 0.41 0.86 (0.46–1.63)
A/A 0.12 0.13 0.12 1.05 (0.41–2.67)
aPosition in the reference sequence of canine chromosome 16 (accession number: NC_006598.3)
Abbreviations: SNPs single nucleotide polymorphisms, HWE Hardy-Weinberg equilibrium
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validated by BLAST (http://blast.ncbi.nlm.nih.gov/). The
sequences were aligned using the MEGA v.5.3 software
[19], which was also used to visualize and quantify the
polymorphisms.
Data analysis
The inter-population differentiation (FST) and the intra-
population genetic variability (FIS) were assessed using
Arlequin version 3.11 [20] and GenePop version 4.0 [21].
The correlation between genetic and geographic distances
was assessed with Mantel test using Arlequin version 3.11
[20]. Logistic regression was performed to evaluate SNPs
and haplotype associations with the infection (case-control)
were assessed using SNPStats software (http://bioinfo.icon
cologia.net/SNPstats_web), assuming a 5% significance level
[22]. Statistical power was calculated using G*Power soft-
ware [23]. This case-control study has > 80% power to iden-
tify a genotype association at the 5% significance level.
Results
The real-time PCR positivity values for L. infantum
were 31.6% (30/95) in São Raimundo Nonato and
36.8% (70/190) in Sobral. The canine population of
Putignano showed a positivity of 33.3% (34/102). Re-
garding the parasitic load among the 134 positive
dogs, one was considered very highly positive, three
were highly positive, nine were medium positive and
121 were low positive (Additional file 1: Table S1).
The PCR product for the CBD1 gene showed a band
size of approximately 600 bp. The specificity of the PCR
Table 2 Association between genetic polymorphisms in β-defensin-1 and with Leishmania infantum in dogs from São Raimundo
Nonato, Brazil
SNP Variation ID Positiona Alleles HWE Possible
genotype
Total
frequency
(n = 95)
Frequency
in cases
(n = 18)
Frequency
in controls
(n = 77)
Odds ratio
(95% CI)
Logistic
regression
(P-value)
SNP1 rs852527703 58881447 C/T 0.22 T/T 0.32 0.43 0.26 1.00 0.10
C/T 0.43 0.43 0.43 0.61 (0.23–1.61)
C/C 0.25 0.13 0.31 0.26 (0.07–0.95)
SNP2 rs852380685 58881356 C/T 0.22 T/T 0.32 0.43 0.26 1.00 0.10
C/T 0.43 0.43 0.43 0.61 (0.23–1.61)
C/C 0.25 0.13 0.31 0.26 (0.07–0.95)
SNP3 rs850814192 58881297 A/G 1 G/G 0.51 0.60 0.46 1.00 0.44
A/G 0.42 0.33 0.46 0.56 (0.22–1.40)
A/A 0.07 0.07 0.08 0.67 (0.12–3.80)
SNP4 rs852670798 58881294 A/C 1 C/C 0.48 0.63 0.42 1.00 0.10
A/C 0.43 0.33 0.48 0.46 (0.18–1.15)
A/A 0.08 0.03 0.11 0.20 (0.02–1.79)
SNP5 rs852439766 58881277 C/T 0.41 T/T 0.20 0.17 0.22 0.50 (0.14–1.84) 0.47
C/T 0.55 0.50 0.57 0.57 (0.21–1.56)
C/C 0.25 0.33 0.22 1.00
SNP6 rs850643698 58881159 A/G 1 G/G 0.08 0.03 0.11 0.20 (0.02–1.79) 0.10
A/G 0.43 0.33 0.48 0.46 (0.18–1.15)
A/A 0.48 0.63 0.42 1.00
SNP7 rs853079810 58881122 A/G 0.41 G/G 0.16 0.13 0.17 0.60 (0.15–2.34) 0.67
A/G 0.54 0.50 0.55 0.68 (0.26–1.78)
A/A 0.31 0.37 0.28 1.00
SNP8 rs851268228 58881093 C/T 0.82 T/T 0.09 0.07 0.11 0.48 (0.09–2.61) 0.53
C/T 0.45 0.40 0.48 0.65 (0.26–1.62)
C/C 0.45 0.53 0.42 1.00
SNP9 rs850702571 58881081 A/G 0.53 G/G 0.64 0.73 0.60 1.00 0.43
A/G 0.31 0.23 0.34 0.56 (0.21–1.53)
A/A 0.05 0.03 0.06 0.44 (0.05–4.22)
aPosition in the reference sequence of canine chromosome 16 (accession number: NC_006598.3)
Abbreviations: SNPs single nucleotide polymorphisms, HWE Hardy-Weinberg equilibrium
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was confirmed by BLAST analysis, which presented high
levels of similarity (99%) with a sequence of the CBD1
gene (AC186962.12), which was used as a reference for
designing the primers used in this study.
All dog samples were sequenced and DNA fragments
of 582 bp were obtained. In the polymorphism analysis,
572 conserved sites and 10 variable sites were detected,
and nine of them were parsimony informative. The in-
formative sites were found in the 5’ untranslated region
(position in the chromosome 16: 58881447) and in in-
tron (position in the chromosome 16: 58881356,
58881297, 58881294, 58881277, 58881159, 58881122,
58881093, 58881081) (see Tables 1, 2 and 3). No poly-
morphic sites were detected in the coding region (exons
1 and 2).
In the population genetics analyses, the FIS for all
SNPs in CBD1 revealed a low inbreeding rate, with
values near zero. The FST (0.016) indicated low gen-
etic differentiation, demonstrating that the three pop-
ulations studied are genetically very similar and can
be evaluated as a single population. The analysis of
allele, genotype and haplotype frequencies showed
agreement with the Hardy-Weinberg equilibrium.
When analysing the three populations together, we
observed that none of SNPs in CBD1 and haplotypes
were associated with the L. infantum infection in
dogs. With regard to the populations of Sobral and
São Raimundo Nonato, data analysis demonstrated
that none of the SNPs in CBD1 found was associated
with the presence of L. infantum (Tables 1 and 2).
Table 3 Association between genetic polymorphisms in β-defensin-1 and with Leishmania infantum in dogs from southern Italy
SNP Variation ID Position a Alleles HWE Possible
genotype
Total
frequency
(n = 102)
Frequency
in cases
(n = 33)
Frequency
in controls
(n = 69)
Odds ratio
(95% CI)
Logistic
regression
(P-value)
SNP1 rs852527703 58881447 C/T 0.16 T/T 0.25 0.30 0.22 0.39 (0.12–1.23) 0.18
C/T 0.42 0.48 0.39 0.44 (0.16–1.23)
C/C 0.33 0.21 0.39 1.00
SNP2 rs852380685 58881356 C/T 0.16 T/T 0.25 0.30 0.22 0.39 (0.12–1.23) 0.18
C/T 0.42 0.48 0.39 0.44 (0.16–1.23)
C/C 0.33 0.21 0.39 1.00
SNP3 rs850814192 58881297 A/G 0.68 G/G 0.39 0.55 0.32 1.00 0.04
A/G 0.45 0.39 0.48 2.08 (0.85–5.08)
A/A 0.16 0.06 0.20 5.73 (1.15–28.57)
SNP4 rs852670798 58881294 A/C 0.24 C/C 0.47 0.30 0.55 1.00 0.05
A/C 0.47 0.64 0.39 0.34 (0.14–0.83)
A/A 0.06 0.06 0.06 0.53 (0.08–3.30)
SNP5 rs852439766 58881277 C/T 0.83 T/T 0.14 0.18 0.12 0.30 (0.08–1.15) 0.06
C/T 0.49 0.61 0.43 0.34 (0.13–0.92)
C/C 0.37 0.21 0.45 1.00
SNP6 rs850643698 58881159 A/G 0.33 G/G 0.06 0.06 0.06 0.58 (0.09–3.59) 0.11
A/G 0.46 0.61 0.39 0.39 (0.16–0.95)
A/A 0.48 0.33 0.55 1.00
SNP7 rs853079810 58881122 A/G 0.67 G/G 0.14 0.18 0.12 0.30 (0.08–1.13) 0.04
A/G 0.44 0.58 0.38 0.31 (0.12–0.82)
A/A 0.42 0.24 0.51 1.00
SNP8 rs851268228 58881093 C/T 0.68 T/T 0.18 0.06 0.23 6.80 (1.36–33.88) 0.02
C/T 0.46 0.42 0.48 2.00 (0.82–4.92)
C/C 0.36 0.52 0.29 1.00
SNP9 rs850702571 58881081 A/G 1 G/G 0.62 0.45 0.70 1.00 0.07
A/G 0.34 0.48 0.28 0.37 (0.15–0.90)
A/A 0.04 0.06 0.03 0.31 (0.04–2.41)
aPosition in the reference sequence of canine chromosome 16 (accession number: NC_006598.3)
Abbreviations: SNPs single nucleotide polymorphisms, HWE Hardy-Weinberg equilibrium
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The genotypes A/A and T/T within the SNPs 3 and 8, re-
spectively, were associated with the risk of L. infantum in-
fection in dogs from Italy. On the other hand, the
genotypes A/C and A/G within the SNPs 4 and 7, respect-
ively, were associated with protection against L. infantum
infection (Table 3).
As far as haplotype association is concerned, no haplo-
types were found to be associated with L. infantum in-
fection in the studied dog populations.
Discussion
In this study, we evaluated the possible association
between SNPs in the CBD1 gene and L. infantum in-
fection in dogs from north-eastern Brazil and south-
ern Italy. We found an association between some
genotypes within SNPs in the CBD1 gene and L.
infantum infection in dogs from Italy, indicating that
these SNPs could be potential genetic markers for the
study of L. infantum infection susceptibility/resistance
in these animals. Yet, no association was found be-
tween SNPs in the CBD1 gene and L. infantum infec-
tion in the dog populations from Brazil, which may
suggest that further studies are needed to confirm the
associations found in Italy. These differences could
also be related to differences in parasite strains infect-
ing dogs in each studied area. This hypothesis is
unlikely because L. infantum zymodeme MON-1 is
the predominant strain of infecting dogs in the Medi-
terranean basin and apparently also in South America
[24–26]. Another issue that should be considered is
population stratification. As all SNPs are potentially under
selection pressure, they may not be reliable to assess
population stratification. Therefore, the associations found
herein could also be due to the underlying structure of the
Italian population.
The association between the SNPs in the CBD1
gene and L. infantum infection in dogs here de-
scribed, along with previous studies demonstrating
the association between other gene polymorphisms
and leishmaniasis in humans [27] and dogs [7–9, 28], in-
dicate that genetic factors may be involved in the suscepti-
bility of L. infantum to infection and disease development.
Studies conducted by Sanchez-Robert et al. [8, 28] re-
ported an association between a haplotype (TAG-8-141)
that includes a SNP in the promoter region and a
microsatellite in intron 1, and two SNPs (A4549G in
intron 6 and C4859T in exon 8) located in the
Slc11a1 gene and susceptibility to leishmaniasis in
dogs. In another study, Quilez et al. [9] found associ-
ations between polymorphisms in several genes (e.g.
Il7R, Lifr, C6, C7 and Csf1r genes) and CanL.
The results of the SNPs association analysis herein
presented indicates that CBD1 gene may be involved
in the immune response of dogs to L. infantum
infection. However, future analysis of the expression
levels of the CBD1 gene in dogs infected with L.
infantum will provide more information about the
function of this gene. A previous study evaluated the
expression of beta-defensins (i.e. CBD1, CBD103 and
CBD108) in the canine respiratory tract and their
antimicrobial activity against the intracellular bacter-
ium Bordetella bronchiseptica [11]. All three investi-
gated beta-defensins were detected in respiratory cells
and were also readily expressed in skin samples. The
study demonstrated that cells infected with canine
parainfluenza virus had lower levels of CBD1 and
CBD108, as well as that CBD103 presents antimicro-
bial activity against B. bronchiseptica. Another study
showed increased expression levels of the CBD1 gene
in the skin of dogs with atopic dermatitis compared
with healthy individuals [12]. Hypothetically, differ-
ences in the expression of the CBD1 gene in the skin
of L. infantum infected dogs could be associated with
the presence/absence/severity of skin lesions com-
monly seen in dogs with CanL. Again, further re-
search is needed to evaluate the functional effects (if
any) of the SNPs found herein and, from a broader
perspective, to assess if CBD1 or other beta-defensins
display any antimicrobial activity against L. infantum.
Conclusion
This study demonstrates for the first time a possible as-
sociation between SNPs in the CBD1 gene and L. infan-
tum infection in dogs. A functional validation of this
hypothesis, for example, to assess the level of expression
of β-defensin-1 in the skin of dogs carrying these SNPs,
would be required.
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